NOVEL INHIBITORS OF HUMAN SYNOVIAL AND HUMAN PLATELET PLA2

被引：0
|
作者：
MUSSER, JH [1 ]
SCHIEHSER, GA [1 ]
MCGREGOR, HC [1 ]
CARLSON, RP [1 ]
CHANG, J [1 ]
MARSHALL, LA [1 ]
机构：
[1] WYETH AYERST RES,PRINCETON,NJ 08543
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1989年 / 198卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：44 / MEDI
相关论文
共 50 条
  • [21] Coronary thrombosis and the platelet glycoprotein IIIA gene PLA2 polymorphism
    Durante-Mangoni, E
    Davies, GJ
    Ahmed, N
    Ruggiero, G
    Tuddenham, EG
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (02) : 218 - 219
  • [22] The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction
    Grove, EL
    Orntoft, TF
    Lassen, JF
    Jensen, HK
    Kristensen, SD
    JOURNAL OF INTERNAL MEDICINE, 2004, 255 (06) : 637 - 644
  • [23] A STUDY OF SERUM PHOSPHOLIPASE-A2 (PLA2) ACTIVITY AS A MARKER OF HUMAN OSTEOARTHRITIS (OA)
    BALBLANC, JC
    MATHIEU, P
    CONROZIER, T
    BROQUET, P
    RICHARD, M
    VIGNON, E
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S322 - S322
  • [24] MEMBRANES EXERT INDIRECT NEGATIVE CONTROL ON PHOSPHOLIPASE-A2 (PLA2) IN HUMAN PLACENTA
    JEREMY, JY
    BARRADAS, MA
    MIKHAILIDIS, DP
    EICOSANOIDS, 1992, 5 (01) : 57 - 57
  • [25] Group I secreted PLA2 in the maintenance of human lower esophageal sphincter tone
    Cao, WB
    Harnett, KM
    Behar, J
    Biancani, P
    GASTROENTEROLOGY, 2000, 119 (05) : 1243 - +
  • [26] Phospholipase inhibition:: Medicinal chemistry and therapeutic potential of PLA2 inhibitors
    Rangappa, K. S.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (08) : 741 - 742
  • [27] Recombinant Production of a PLA2 Inhibitor: Implications for Production of Venom Inhibitors
    Elmashhady, Hady
    Loh, Chin Yi
    Michael, Chris
    Ma, Minh
    Sahudin, Sydney
    Schutz, Victoria
    FASEB JOURNAL, 2016, 30
  • [28] Increased platelet aggregability associated with platelet GPIIIα PlA2 polymorphism -: The Framingham Offspring Study
    Feng, DL
    Lindpaintner, K
    Larson, MG
    Rao, VS
    O'Donnell, CJ
    Lipinska, I
    Schmitz, C
    Sutherland, PA
    Silbershatz, H
    D'Agostino, RB
    Muller, JE
    Myers, RH
    Levy, D
    Tofler, GH
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (04) : 1142 - 1147
  • [29] Platelet GPIIIa PlA2 polymorphism, fibrinogen levels and platelet aggregability: The Framingham heart study
    Feng, DL
    Lindpaintner, K
    Larson, MG
    O'Donnell, CJ
    Lipinska, I
    Sutherland, PA
    D'Agostino, RB
    Tofler, GH
    CIRCULATION, 1999, 100 (18) : 327 - 327
  • [30] DEVELOPMENT OF A SERIES OF POTENT SELECTIVE PLA2 INHIBITORS WITH INVIVO ACTIVITY
    CAUFIELD, CE
    RINKER, JM
    VONBURG, G
    GLASER, K
    MARSHALL, L
    SUNG, A
    LOCK, T
    BAUER, J
    CARLSON, RP
    CHANG, JY
    WEICHMAN, BM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 205 : 106 - MEDI
12345